Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 58.78 USD -2.05% Market Closed
Market Cap: 5.3B USD
Have any thoughts about
Crinetics Pharmaceuticals Inc?
Write Note

Crinetics Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Crinetics Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Total Equity
$830.8m
CAGR 3-Years
60%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Crinetics Pharmaceuticals Inc's Total Equity?
Total Equity
830.8m USD

Based on the financial report for Jun 30, 2024, Crinetics Pharmaceuticals Inc's Total Equity amounts to 830.8m USD.

What is Crinetics Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 5Y
42%

Over the last year, the Total Equity growth was 227%. The average annual Total Equity growth rates for Crinetics Pharmaceuticals Inc have been 60% over the past three years , 42% over the past five years .

Back to Top